PT  - JOURNAL ARTICLE
AU  - Müller, Sebastian A
AU  - Balmer, Michael
AU  - Charlton, Billy
AU  - Ewert, Ricardo
AU  - Neumann, Andreas
AU  - Rakow, Christian
AU  - Schlenther, Tilmann
AU  - Nagel, Kai
TI  - Using mobile phone data for epidemiological simulations of lockdowns: government interventions, behavioral changes, and resulting changes of reinfections
AID  - 10.1101/2020.07.22.20160093
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.22.20160093
4099  - http://medrxiv.org/content/early/2020/08/28/2020.07.22.20160093.short
4100  - http://medrxiv.org/content/early/2020/08/28/2020.07.22.20160093.full
AB  - Epidemiological simulations as a method are used to better understand and predict the spreading of infectious diseases, for example of COVID-19. This paper presents an approach that combines person-centric data-driven human mobility modelling with a mechanistic infection model and a person-centric disease progression model. Results show that in Berlin (Germany), behavioral changes of the population mostly happened before the government-initiated so-called contact ban came into effect. Also, the model is used to determine differentiated changes to the reinfection rate for different interventions such as reductions in activity participation, the wearing of masks, or contact tracing followed by quarantine-at-home. One important result is that successful contact tracing reduces the reinfection rate by about 30 to 40%, and that if contact tracing becomes overwhelmed then infection rates immediately jump up accordingly, making rather strong lockdown measures necessary to bring the reinfection rate back to below one.Competing Interest StatementKN and MB own shares of Senozon, the company which generates the synthetic movement traces.Funding StatementThe work on the paper was funded by the Ministry of research and education (BMBF) Germany(01KX2022A) and TU Berlin.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:n/aAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAccess to computer code and output data is provided in the paper. Access to input data is unfortunately on "reasonable" request only, as specified in the paper. https://github.com/matsim-org/matsim-episim https://svn.vsp.tu-berlin.de/repos/public-svn/matsim/scenarios/countries/de/episim/output-data/stability1.zip https://svn.vsp.tu-berlin.de/repos/public-svn/matsim/scenarios/countries/de/episim/output-data/stability2.zip https://svn.vsp.tu-berlin.de/repos/public-svn/matsim/scenarios/countries/de/episim/output-data/interventions0703/ https://covid-sim.info/